Yatindra M. Joshi, Ph.D., joined CutisPharma as a Special Advisor to the Board of Directors in April 2017. Dr. Joshi is a seasoned pharmaceutical industry executive with over 30 years of experience, currently serving as Partner at YMJ Consultants LLC. Dr. Joshi also serves as Chairman of the Board of Neoprol Ltd and is a member of the Board of Directors of Tapemark. Prior to his current appointments, Dr. Joshi served as the Senior Vice President, Generic R&D- North America, at Teva Pharmaceutical Corporation. Prior to that, Dr. Joshi served in Senior Leadership positions of increasing responsibility at Novartis and Bristol Myers Squibb. Throughout his career, Dr. Joshi has had a very successful track record of developing branded and generic products with varying complexity and variety of dosage forms from the laboratory to commercialization. Dr. Joshi authored 29 publications and has 19 patents. He has lectured extensively on QbD, drug delivery, pharmaceutical education, and forward-looking topics like Pharma 2020. He received his MBA from the Wharton School of Business, University of Pennsylvania, his Ph.D. in Chemistry from Dalhousie University, Halifax, NS, and his BS and MS degrees in Chemistry from Delhi University, Delhi, India.
©2017 CutisPharma, Inc.
FI℞ST® and the FI℞ST® logo are registered
trademarks of CutisPharma, Inc.